Skip to main content

Closed

ARDX: Ardelyx, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+168.1% / yr

Operating margin-8.7%

ROIC-9.4%

Financially safe

Stretched

Debt / equity1.40×

Interest coverage-1.3×

Current ratio3.49×

Ardelyx, Inc.

ARDXNASDAQ Global Market·USD·Closed

Ardelyx, Inc.

ARDXNASDAQ·USD·Closed

$4.95

−1.79%

$4.95

−$0.09 (1.79%)

52W Range

20thpctl

Volume

0.71×avg

Mkt Cap

1.22BUSD

P/E

-21.0TTM

Div Yield

–ann

52W Range

20thpctl

Volume

0.71×avg

Market Cap

1.22BUSD

P/E Ratio

-21.0TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings